PAOA


  • Specification
  • Related Products
Cat.No.:  BSM-0380
Product Name:  PAOA
CAS No.:  537034-15-4
Figure: 
Synonyms:  Histone Deacetylase Inhibitor IV
Product Overview:  A selective HDAC1/3 inhibitor
Description:  PAOA is a selective histone deacetylase (HDAC) inhibitor with IC50 values of 199 and 69 nM for HDAC1 and HDAC3, respectively. It is selective for HDAC1 and HDAC3, having IC50 values greater than 1.59 μM for HDAC2, 4, 5, 7, and 8 in a cell-free enzyme assay. In vitro, PAOA induces histone H3 and H4 hyperacetylation. PAOA improves the metabolic deficit exhibited by murine striatal cells isolated from HdhQ111 knock-in mice in a dose-dependent manner and reduces eye neurodegeneration. melanogaster model of Huntington’s disease. In vivo, PAOA prevents formation of Huntingtin (Htt) protein aggregates in the brain and reduces the cognitive deficits in the N171-82Q mouse model of Huntington’s disease.
Appearance:  A crystalline solid
Molecular Weight:  325.4
Purity:  ≥95%
Storage:  -20°C
Targets:  HDAC1; HDAC3
Molecular Formula:  C19H23N3O2
Chemical Name:  N1-(2-aminophenyl)-N7-phenyl-heptanediamide
Warning:  For Research Use Only! Not For Use in Humans.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.